PUBLIC CONTRACT · 2018
P259-2018-100 - Oxaliplatina
- Contract value
- €8,448.54
- Signed on
- 23 August 2018
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4878720PUBLISHED DESCRIPTION
Aquisição centralizada SPMS - P259-2018-100 - OXALIPLATINA
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Porto, Porto
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- FRESENIUS KABI PHARMA PORTUGAL · Tax ID 504293753
- Bidder
- ASTELLAS FARMA, LDA · Tax ID 502540249
- Bidder
- Amgen · Tax ID 502942959
- Bidder
- Novartis Farma, S. A. · Tax ID 500063524
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €8,448.54
- Procedure base price
- €2,082,032.72
- Total effective price
- Not reported on Portal BASE
- Publication date
- 16 October 2018
- Award date
- 31 July 2018
- Signing date
- 23 August 2018
- Performance period
- 126 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2015/47 - Acordo quadro para fornecimento de medicamentos do aparelho locomotor às instituições e serviços do serviço nacional de saúde
- Centralised procedure
- Yes
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3516198
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.